MedPath

Phase II study of vitamin B12 and folate supplementation for patients undergoing chemotherapy with pemetrexed.

Not Applicable
Conditions
on-small cell lung cancer, Malignant pleural mesothelioma
Registration Number
JPRN-UMIN000010570
Lead Sponsor
Tokyo Metropolitan Cancer and Infectious diseases Center Komagome Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
140
Inclusion Criteria

Not provided

Exclusion Criteria

1. Extensive interstitial pneumonitis 2. Severe complications 3. Active infection 4. Allergy to treatment drugs 5. Pregnant or breast-feeding 6. Unable to take drugs orally 7. Other conditions inadequate for this research

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath